相关实验视频

Updated: May 2, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.8K

在多发性硬化症中,基于血液的生物标志物的诊断潜力

Signe Holm Nielsen1, Morten Karsdal1, Bruna Manoel1

  • 1Nordic Bioscience, Herlev, Denmark.

Frontiers in neurology
|January 15, 2025
PubMed
概括

新的血液生物标志物显示出对诊断多发性硬化症 (MS) 的希望. 这些生物标志物检测组织损伤中的蛋白质碎片,可以帮助更早,更准确地诊断MS.

关键词:
基于血液的生物标志物诊断 诊断 诊断 诊断 诊断 诊断碎片碎片碎片碎片的碎片多发性硬化症多发性硬化症蛋白质是一种蛋白质.

更多相关视频

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets11:03

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

7.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.8K

相关概念视频

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20